Evidence map›Paper›PMID 24436572›Full record

ArticleCurrent trends in endocrinology2012

Fatty acid metabolism and thyroid hormones.

Naomi L Sayre, James D Lechleiter

Open access · greenAbstract read
In one paragraph

Article in Current trends in endocrinology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Thyroid hormone signaling in the intestinal stem cells and their niche.Cellular and molecular life sciences : CMLS · 2022
    Review
  13. Article
  14. Article
  15. Metabolic and Energy Imbalance in Dysglycemia-Based Chronic Disease.Diabetes, metabolic syndrome and obesity : targets and therapy · 2021
    Review
  16. The Swing of Lipids at Peroxisomes and Endolysosomes in T Cell Activation.International journal of molecular sciences · 2020
    Review
  17. The role of thyroid hormone in metabolism and metabolic syndrome.Therapeutic advances in endocrinology and metabolism · 2020
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Naomi L SayreDepartment of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, South Texas Research Facility Neuroscience Center, 8403 Floyd Curl Drive, San Antonio, TX 78229-3904, USA.
James D LechleiterDepartment of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, South Texas Research Facility Neuroscience Center, 8403 Floyd Curl Drive, San Antonio, TX 78229-3904, USA.
The University of Texas Health Science Center at San Antonio · US

Funding

ROLE OF CASPASE-2 IN OSTEOCOLAST APOPTOSIS AGE-EePENDENT OSTEOPOROSISP01AG019316 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI HERMAN, BRIAN A. · 2001 to 2011
$11.3M
In vivo neuroprotective role of astrocyte mitochondrial metabolism during agingR01AG029461 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI LECHLEITER, JAMES D · 2008 to 2012
$1.6M
NIA NIH HHS P01 AG019316NIA NIH HHS R01 AG029461NINDS NIH HHS L30 NS080261
6 · The paper itself

Abstract

The importance of thyroid hormone signaling in the acute regulation of metabolic activity has been recognized for decades. Slowly, the underlying mechanisms responsible for this activity are being elucidated. A prominent characteristic of thyroid signaling is rapid increases in oxygen consumption and ATP production. This discovery implicated a non-genomic regulation of mitochondrial metabolism by thyroid hormones. Another important clue came from the discovery that thyroid hormones stimulated fatty acid oxidation (FAO) in a variety of tissues in a receptor-dependent, but transcriptional-independent manner. Recently, key linkages between thyroid hormone signaling and specific mitochondrial-targeted pathways have been discovered. This review focuses on the molecular mechanisms by which mitochondrial FAO can be increased through thyroid hormone signaling. The roles of both the full-length and shortened mitochondrial isoforms of thyroid hormone receptor will be discussed. Additionally, the impact of thyroid hormone signaling on dyslipidemias such as obesity, type II diabetes, and fatty liver disease will be considered.

Indexed as

3,3,5 triiodothyronineACCacetyl-coA carboxylaseadenosine monophosphate activated protein-kinaseAMPKcarnitine palmitoyl transferasec-erbACO23CPTdyslipidemiaenergy homeostasisfatty acidfatty acid oxidationfatty acid traffickingGC-1insulin resistanceLCHADlong-chain acyl CoA dehydrogenaseMB07344metabolic syndromemitochondriamitochondrial trifunctional proteinMTPnon-alcoholic fatty liver diseasenon-genomicobesityp28p30p43steatosisT2T3,3,5 diiodothyroininethyroid hormonethyroid hormone analogsthyroid hormone receptorthyrotoxicityTRαTRβtype II diabetes

Identifiers

PMID24436572
PMCPMC3891511
OpenAlexW1554160015

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.